克隆造血的进化动态和健康格局
Caroline J Watson1,2, A L Papula3, Gladys Y P Poon4,2
1Department of Oncology, University of Cambridge, Cambridge, UK. cw672@cam.ac.uk jrb75@cam.ac.uk.
概括
老化血液中的体质突变与癌症风险有关. 我们的研究揭示了正确的选择, 而不是偶然, 驱动这些突变, 量化它们的健康优势和对克隆造血的影响.
科学领域:
- 遗传学
- 癌症生物学
- 计算生物学
背景情况:
- 随着年龄的增长,体内突变会在健康的组织中积累,影响癌症的风险.
- 基因漂移与积极选择在克隆造血形成中的作用尚不清楚.
研究的目的:
- 调查健康血液中影响遗传多样性的力量 (突变,遗传漂移,健康).
- 确定克隆性血液形成的变异是否随机发生或是否赋予体能优势.
- 测量常见突变的驱动基因的适应性.
主要方法:
- 分析了大约5万个人的血液测序数据.
- 应用种群遗传学原理来模拟突变,漂移和选择.
- 变种适应性优势的单核酸分辨率量化.
主要成果:
- 积极选择被确定为克隆造血的主要驱动因素,超过了遗传漂移.
- 提供血造干细胞数量的估计.
- 关键致病变体的适应性优势和适应性影响的分布被量化.
结论:
- 克隆造血主要是由对突变的积极选择决定的.
- 这些发现表明随着年龄的增长,基因突变和克隆扩张的风险持续存在.
- 这项研究提供了关于衰老和癌症倾向的遗传情景的见解.
相关概念视频
Hematopoiesis
8.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.2K
Overview of Hematopoiesis
8.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.0K
Regulation of Hematopoietic Stem Cells
3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Multipotency of Hematopoietic Stem Cells
3.7K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.7K
Lineage Commitment
3.9K
Commitment is the process whereby stem cells:
3.9K
Production of Formed Elements
3.5K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
3.5K


